Refractory acute myeloid leukemia (AML)
Clinical trials for Refractory acute myeloid leukemia (AML) explained in plain language.
Never miss a new study
Get alerted when new Refractory acute myeloid leukemia (AML) trials appear
Sign up with your email to follow new studies for Refractory acute myeloid leukemia (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes on tough blood cancers in early trial
Disease control Recruiting nowThis early-stage study tests an oral drug called AUTX-703 in 34 adults with relapsed or hard-to-treat acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). The main goal is to check safety and find the right dose. It's an open-label trial, meaning everyone knows they'r…
Matched conditions: REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
Phase 1 • Sponsor: Auron Therapeutics, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Experimental CAR t therapy takes on tough leukemia
Disease control Recruiting nowThis early-phase trial tests a new treatment called CD64 CAR T cells for adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to target and attack leukemia cells. The m…
Matched conditions: REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
Phase 1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for tough blood cancers: first human trial launches
Disease control Recruiting nowThis study tests a new drug called STX-0712 in people with advanced types of blood cancer (CMML or AML) who have run out of standard treatments. The main goal is to find a safe dose and see how the body handles the drug. About 105 participants will take part in this early-phase t…
Matched conditions: REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
Phase 1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC